Obviously, the expression of TROP2 in PTC was related to lymph node metastasis, tumor size and capsular infiltration (P<0.05), but not to sex, age, and Hashimoto's thyroiditis complications (P>0.05; Table 2). Here, TACSTD2 is linked to neoplasm.